Event Details

KemPharm® is a clinical stage, specialty pharmaceutical company engaged in the development and discovery of proprietary prodrugs that are designed to be improved versions of widely prescribed and FDA approved products.

KemPharm at the RBC Capital Markets 2018 Global Healthcare Conference

Feb 21, 2018 at 4:05 PM EST